Clinical Research Directory
Browse clinical research sites, groups, and studies.
Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY Trial
Sponsor: ANRS, Emerging Infectious Diseases
Summary
HPVsign is a cross-sectional, non-comparative, multicenter study involving all participants included in the HPV substudy of the ANRS IPERGAY trial. The study proposes to evaluate the cumulative incidence of high-grade lesions and/or anal cancers using high-resolution anoscopy (HRA) during the HPVsign study and/or diagnosed since the end of participation in the ANRS IPERGAY trial.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2025-03-20
Completion Date
2027-07-30
Last Updated
2025-12-04
Healthy Volunteers
Yes
Conditions
Interventions
High-resolution anoscopy
The study includes 2 visits: * a medical consultation for inclusion * a proctology consultation including the performance of an AHR associated or not with biopsy sampling
Locations (3)
Hôpital de la Croix Rousse - SMIT
Lyon, France
Hôpital Saint-Louis - SMIT
Paris, France
Hôpital Tenon - SMIT
Paris, France